A targeted blood panel designed to identify potential early warning signs of male-specific cancers, enabling timely follow-up and management. Measures selected tumour markers relevant to male cancers, such as PSA for prostate cancer, AFP for testicular cancer, and other clinically appropriate markers. Intended as a complementary screening tool, not a diagnostic replacement for imaging or specialist evaluation.
The biomarkers analysed are linked to several cancer types, including:
We'll help you find the Best solution For You
Copyright © AEON. All Rights Reserved. MOH: BTQWCN33-210125